Gut microbiota-mediated xanthine metabolism is associated with resistance to high-fat diet-induced obesity

Bin Wei1, Sijia Wang1, Yakun Wang1

  • 1College of Pharmaceutical Science & Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, China.

Insights

Mice resistant to high-fat diet-induced obesity (DIR) exhibit distinct metabolic profiles and gut microbiota compared to obese mice (DIO). Xanthine metabolism, influenced by gut bacteria, correlates with this resistance, offering potential anti-obesity strategies.

Area of Science:

  • Metabolomics and Microbiomics
  • Obesity Research
  • Gut Microbiota and Host Metabolism

Background:

  • High-fat diet-induced obesity (DIO) is a growing concern, yet mechanisms of resistance (DIR) remain unclear.
  • Understanding the interplay between diet, metabolism, and gut microbiota in DIR is crucial for anti-obesity drug discovery.
  • Previous studies have not fully elucidated the metabolic status and gut microbial composition in DIR mice.

Purpose of the Study:

  • To investigate the relationship between metabolic profile, gut microbiota composition, and body weight in mice resistant to high-fat diet-induced obesity (DIR).
  • To compare the metabolic and microbial characteristics of DIR mice with diet-induced obesity (DIO) and control mice.
  • To identify potential biomarkers and pathways associated with resistance to diet-induced obesity.

Main Methods:

  • C57BL/6J mice were fed either a chow or high-fat diet for 8 weeks.
  • Urinary metabolomic analysis using ultraperformance liquid chromatography-tandem mass spectrometry.
  • Fecal microbiome analysis using 16S rRNA gene sequencing and PICRUSt for functional metagenome prediction.

Main Results:

  • High-fat diet increased body weight and fasting blood glucose in DIO mice, but not body weight in DIR mice.
  • DIR mice exhibited a distinct urinary metabolic pattern compared to DIO mice, primarily driven by xanthine.
  • Gut microbiota dysbiosis occurred in both DIO and DIR mice, but specific beneficial bacteria (Bifidobacteriaceae, Roseburia, Escherichia) were maintained in DIR mice, impacting FormylTHF biosynthesis I.

Conclusions:

  • Gut microbiota composition and function are significantly altered in mice resistant to high-fat diet-induced obesity.
  • Xanthine metabolism, influenced by gut microbiota, is a key factor associated with resistance to diet-induced obesity.
  • Targeting gut microbiota-mediated xanthine metabolism may offer a novel therapeutic strategy for combating obesity.

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
83
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.0K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
118